Delivery Order SPE2DR25D3301-SPE2DR26F18SQ
- Not listed
- The Defense Logistics Agency awarded a $12,017.36 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 14, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Mekinist 2mg tablets (30-count) with a ceiling value of $30,573.66. This firm fixed-price delivery order represents a non-competitive set-aside contract and is scheduled for completion by January 6, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $19,566.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a non-competitive delivery order mechanism. The contract was awarded on November 10, 2025, with an ultimate completion date of December 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting the...
- The Defense Logistics Agency awarded a $48.7 million delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was made on December 2, 2025, with an ultimate completion date of December 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.83 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. The delivery order, issued on October 27, 2025, with a completion date of November 18, 2025, represents a non-competitive, non-set-aside award to support federal pharmaceutical procurement needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,806.61 to AmerisourceBergen Drug Corp for 90 milliliters of Mekinist 0.05 mg/ml solution, with a completion date of October 17, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Mekinist 0.05 mg/mL solution in a 90 mL quantity, with a ceiling value of $5,576.15. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and was competitively awarded without set-aside restrictions. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,341.02 to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) on September 24, 2025, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,191.22 for 30 tablets of Mekinist 2 mg on December 23, 2025, with an ultimate completion date of January 15, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement of the oncology medication and contains no subcontractor information. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F18SQDelivery Order
The Defense Logistics Agency awarded a $8,226.96 delivery order to AmerisourceBergen Drug Corp for Mekinist 0.05 mg/ml solution (90 ml), an oncology medication used in cancer treatment. This non-set-aside, firm fixed-price delivery order was awarded on November 28, 2025, with an ultimate completion date of December 19, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government healthcare entities. The company's portfolio demonstrates extensive capability in delivering both brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains. As a child contract under the SPE2DX prime IDC, this Mekinist delivery order reflects AmerisourceBergen's ongoing role in fulfilling the Defense Logistics Agency's medical supply chain requirements through competitively awarded contracts with firm fixed pricing across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 11/27/25 |